Haystack Oncology
Baltimore
About Haystack Oncology
Haystack Oncology, an oncology company, uses the most recent circulating tumor DNA detection technology to enhance the diagnosis of minimum residual disease and provide superior therapy decision-making information.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $56.0M
- Funding stage: M&A
- Last round: Series A (Nov 2022)
- Website: haystackoncology.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/haystack-oncology-118982 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.